Certain Stock Options of Catalyst Pharmaceuticals, Inc. are subject to a Lock-Up Agreement Ending on 4-APR-2024. These Stock Options will be under lockup for 91 days starting from 4-JAN-2024 to 4-APR-2024.

Details:
Our executive officers and directors have entered into lock-up agreements with the underwriters prior to the commencement of this prospectus supplement to which each of these persons, with limited exceptions, for a period of 90 days after the date of this prospectus supplement, may not, without the prior written consent of BofA Securities, Inc.